| Lindsay Ann Johnson, PHARMD | |
|
22700 W 55th Ter, Shawnee, KS 66226-5602 | |
| (913) 422-1825 | |
| (913) 422-1079 |
| Full Name | Lindsay Ann Johnson |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 22700 W 55th Ter, Shawnee, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629239298 | NPI | - | NPPES |
| 100098080C | Other | KS | SED WAIVER |
| 100098080A | Medicaid | KS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TB0200X | Psychologist - Cognitive & Behavioral | 1174 (Kansas) | Secondary |
| 183500000X | Pharmacist | 1-100468 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lindsay Ann Johnson, PHARMD 22700 W 55th Ter, Shawnee, KS 66226-5602 Ph: (913) 422-1825 | Lindsay Ann Johnson, PHARMD 22700 W 55th Ter, Shawnee, KS 66226-5602 Ph: (913) 422-1825 |
News Archive
An innovative use for a known drug is showing promise as an effective treatment for preventing postoperative nausea and vomiting, suggests a study published today in the Online First edition of Anesthesiology, the peer-reviewed medical journal of the American Society of Anesthesiologists.
Bioengineers at The University of Texas at Dallas have created a novel gene-delivery system that shuttles a gene into a cell, but only for a temporary stay, providing a potential new gene-therapy strategy for treating disease.
Democratic vice presidential nominee Sen. Joseph Biden (Del.) on Tuesday during a campaign event in Mehlville, Mo., said that Republican presidential nominee Sen. John McCain (Ariz.) as president would place employer-sponsored health insurance at risk, the St. Louis Post-Dispatch reports.
Autism spectrum disorder (ASD) is rarely diagnosed until symptoms arise, often well into childhood. Evidence however, is mounting that developmental abnormalities likely emerge in the brain long before then: early identification of babies at risk for ASD could allow for interventions that would improve their developmental outcomes.
The absence of technical standards in the Medical Device Directive has forced medical imaging companies to conform to additional, country specific standards. The presence of multilayered and diffused national legislatives in a stringent regulatory environment has invariably complicated product and technology innovation.
› Verified 9 days ago